US Patent Issued to ACADEMY OF MILITARY MEDICAL SCIENCES, AMS, PLA on June 10 for "mRNA vaccine encoding fusion antigen against Mpox and severe acute respiratory syndrome coronavirus 2" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,324,835, issued on June 10, was assigned to ACADEMY OF MILITARY MEDICAL SCIENCES, AMS, PLA (Beijing).

"mRNA vaccine encoding fusion antigen against Mpox and severe acute respiratory syndrome coronavirus 2" was invented by Yilong Yang (Beijing), Wei Chen (Beijing), Junjie Xu (Beijing), Xiaofan Zhao (Beijing), Jun Zhang (Beijing), Lihua Hou (Beijing), Xiaodong Zai (Beijing) and Yu Li (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "An mRNA molecule is disclosed. The mRNA molecule contains a polynucleotide encoding an M1R antigen of Mpox and a polynucleotide encoding an RBD antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and...